Company: HCTI
Filing Date: 2025-04-01
Form Type: S-1
Source: 0001213900-25-027277
Chunk: 3

Company: Healthcare Triangle, Inc.
Filing Date: 2025-04-01
Form: S-1
Chunk 3
---
 Purchase Warrants. However, we will incur expenses in connection with
the registration of the shares of our Common Stock offered hereby.

The
selling stockholders may sell these shares through public or private transactions at market prices prevailing at the time of sale or at
negotiated prices. The timing and amount of any sale are within the sole discretion of each selling stockholder. The selling stockholders
and any underwriters, dealers or agents that participate in distribution of the securities may be deemed to be underwriters, and any profit
on sale of the securities by them and any discounts, commissions or concessions received by any underwriter, dealer or agent may be deemed
to be underwriting discounts and commissions under the Securities Act. There can be no assurances that the selling stockholders will sell
any or all of the securities offered under this prospectus.

For
further information regarding the possible methods by which the shares may be distributed, see the section titled “Plan of Distribution” beginning on page 20 of this prospectus. We will bear all costs, expenses and fees in connection with the
registration of the shares of Common Stock. The selling stockholders will bear all commissions and discounts, if any, attributable to
their sales of the shares of Common Stock.

Our Common Stock is listed
on the Nasdaq Capital Market LLC (“Nasdaq”) under the symbol “HCTI”. On March 31, 2025, the closing sale price
of our Common Stock as reported on Nasdaq was $0.2996.

Investment in our Common Stock involves risk. See “Risk Factors” contained in this prospectus, in our periodic reports filed from time to time with the Securities and Exchange Commission, which are incorporated by reference in this prospectus and in any applicable prospectus supplement. You should carefully read this prospectus and the documents we incorporate by reference, before you invest in our Common Stock.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or the accuracy of this prospectus. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is , 2025

Table of Contents</div>

| ABOUT THIS PROSPECTUS                             |     |  ii |
| MARKET DATA                                       |     | iii |
| PROSPECTUS SUMMARY                                |     |   1 |
| RISK FACTORS                                      |     |   5 |
| SPECIAL NOTE REGARDING FORWARD-LOOK